Steven Lacy

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Liquid dosage forms to treat cancer
- Patent number 12,016,854
- Issue date Jun 25, 2024
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Liquid dosage forms to treat cancer
- Patent number 11,504,362
- Issue date Nov 22, 2022
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyqu...
- Patent number 11,141,413
- Issue date Oct 12, 2021
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...
- Patent number 10,273,211
- Issue date Apr 30, 2019
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING
Information Patent Grant
Dosing of cabozantinib formulations
- Patent number 10,159,666
- Issue date Dec 25, 2018
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20240350477
- Publication date Oct 24, 2024
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Liquid Dosage Forms to Treat Cancer
- Publication number 20240307367
- Publication date Sep 19, 2024
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N...
- Publication number 20240287002
- Publication date Aug 29, 2024
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING
Information Patent Application
Liquid Dosage Forms to Treat Cancer
- Publication number 20230301978
- Publication date Sep 28, 2023
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20230045783
- Publication date Feb 9, 2023
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20220401433
- Publication date Dec 22, 2022
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20220000857
- Publication date Jan 6, 2022
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...
- Publication number 20210002228
- Publication date Jan 7, 2021
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING
Information Patent Application
Liquid Dosage Forms to Treat Cancer
- Publication number 20200268737
- Publication date Aug 27, 2020
- Exelixis, Inc.
- Khalid Shah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing of Cabozantinib Formulations
- Publication number 20200163954
- Publication date May 28, 2020
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...
- Publication number 20190218182
- Publication date Jul 18, 2019
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING
Information Patent Application
Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...
- Publication number 20190209547
- Publication date Jul 11, 2019
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing of Cabozantinib Formulations
- Publication number 20190076420
- Publication date Mar 14, 2019
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing of Cabozantinib Formulations
- Publication number 20170087143
- Publication date Mar 30, 2017
- Exelixis, Inc.
- Dana T. Aftab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Metabolites of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dic...
- Publication number 20160031818
- Publication date Feb 4, 2016
- Exelixis, Inc.
- Dana T. Aftab
- G01 - MEASURING TESTING

Steven Lacy

Person

Patents Grantslast 30 patents

Liquid dosage forms to treat cancer

Liquid dosage forms to treat cancer

Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyqu...

Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...

Dosing of cabozantinib formulations

Patents Applicationslast 30 patents

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

Liquid Dosage Forms to Treat Cancer

METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N...

Liquid Dosage Forms to Treat Cancer

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...

Liquid Dosage Forms to Treat Cancer

Dosing of Cabozantinib Formulations

Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N...

Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyqu...

Dosing of Cabozantinib Formulations

Dosing of Cabozantinib Formulations

Metabolites of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dic...